WUHU TOKEN SCIENCES CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.17 CNY | -0.77% |
|
+6.38% | -22.72% |
| Apr. 26 | Wuhu Token Sciences Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
| Apr. 25 | Wuhu Token Sciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 23,744 | 21,758 | 32,601 | 14,656 | 16,423 | 12,692 | - |
| Enterprise Value (EV) 1 | 23,744 | 21,023 | 32,066 | 13,844 | 16,919 | 12,377 | 12,056 |
| P/E ratio | 29.3 x | 26.1 x | 36.9 x | 21.3 x | 66.9 x | 17.4 x | 12.4 x |
| Yield | 0.97% | 1.12% | 0.38% | 1.68% | 1.05% | 1.46% | 1.53% |
| Capitalization / Revenue | 3.94 x | 3.18 x | 4.64 x | 2.1 x | 1.85 x | 1.38 x | 1.18 x |
| EV / Revenue | 3.94 x | 3.07 x | 4.57 x | 1.98 x | 1.9 x | 1.35 x | 1.12 x |
| EV / EBITDA | 16.7 x | 13.8 x | 18.8 x | 9.25 x | 13.9 x | 7.48 x | 6.29 x |
| EV / FCF | - | - | -177,410,049 x | 37,431,471 x | -29,407,122 x | - | - |
| FCF Yield | - | - | -0% | 0% | -0% | - | - |
| Price to Book | 3.95 x | 3.12 x | 4.25 x | 1.78 x | 2 x | 1.39 x | 1.27 x |
| Nbr of stocks (in thousands) | 2,311,974 | 2,447,483 | 2,454,857 | 2,454,915 | 2,454,919 | 2,454,922 | - |
| Reference price 2 | 10.27 | 8.890 | 13.28 | 5.970 | 6.690 | 5.170 | 5.170 |
| Announcement Date | 3/1/20 | 4/26/21 | 4/22/22 | 4/14/23 | 4/25/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 6,024 | 6,844 | 7,018 | 6,987 | 8,889 | 9,186 | 10,785 |
| EBITDA 1 | 1,424 | 1,520 | 1,710 | 1,497 | 1,220 | 1,655 | 1,916 |
| EBIT 1 | 1,027 | 962.6 | 1,051 | 733 | 313.9 | 934 | 1,143 |
| Operating Margin | 17.04% | 14.07% | 14.97% | 10.49% | 3.53% | 10.17% | 10.6% |
| Earnings before Tax (EBT) 1 | 1,024 | 994.4 | 1,060 | 729.6 | 316.4 | 896 | 1,230 |
| Net income 1 | 845.4 | 834.2 | 904.2 | 679.7 | 241.6 | 729.8 | 1,022 |
| Net margin | 14.03% | 12.19% | 12.88% | 9.73% | 2.72% | 7.94% | 9.48% |
| EPS 2 | 0.3500 | 0.3400 | 0.3600 | 0.2800 | 0.1000 | 0.2978 | 0.4155 |
| Free Cash Flow | - | - | -180.7 | 369.9 | -575.3 | - | - |
| FCF margin | - | - | -2.58% | 5.29% | -6.47% | - | - |
| FCF Conversion (EBITDA) | - | - | - | 24.71% | - | - | - |
| FCF Conversion (Net income) | - | - | - | 54.42% | - | - | - |
| Dividend per Share 2 | 0.1000 | 0.1000 | 0.0500 | 0.1000 | 0.0700 | 0.0757 | 0.0790 |
| Announcement Date | 3/1/20 | 4/26/21 | 4/22/22 | 4/14/23 | 4/25/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,936 | 1,717 | 1,496 | 1,965 | 1,810 | 1,472 | 1,903 | 2,921 | 2,593 | 5,514 |
| EBITDA | 196.8 | - | 318.3 | 360.7 | - | - | - | - | - | - |
| EBIT 1 | 130.3 | - | 220.8 | 238.6 | 48.04 | - | - | - | -68.52 | 51.89 |
| Operating Margin | 6.73% | - | 14.76% | 12.14% | 2.66% | - | - | - | -2.64% | 0.94% |
| Earnings before Tax (EBT) 1 | 133.9 | - | 221.7 | 239.7 | 43.08 | - | - | - | -68.02 | 53.45 |
| Net income 1 | 104.8 | 181.4 | 183.3 | 218.5 | 96.46 | - | - | - | -64.03 | 21.89 |
| Net margin | 5.41% | 10.56% | 12.26% | 11.12% | 5.33% | - | - | - | -2.47% | 0.4% |
| EPS 2 | 0.0400 | 0.0726 | 0.0800 | 0.0900 | 0.0400 | - | 0.0500 | 0.0300 | -0.0200 | 0.0100 |
| Dividend per Share | 0.0500 | - | - | - | 0.1000 | - | - | - | - | - |
| Announcement Date | 4/22/22 | 4/22/22 | 8/29/22 | 10/24/22 | 4/14/23 | 4/24/23 | 8/25/23 | 10/27/23 | 4/25/24 | 4/25/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 495 | - | - |
| Net Cash position 1 | - | 735 | 534 | 812 | - | 315 | 636 |
| Leverage (Debt/EBITDA) | - | - | - | - | 0.4063 x | - | - |
| Free Cash Flow | - | - | -181 | 370 | -575 | - | - |
| ROE (net income / shareholders' equity) | 16.1% | 12.6% | 12.3% | 8.37% | 2.89% | 8.11% | 10.5% |
| ROA (Net income/ Total Assets) | 9.22% | - | 8.43% | 5.52% | - | 5.12% | 6.5% |
| Assets 1 | 9,172 | - | 10,726 | 12,314 | - | 14,241 | 15,713 |
| Book Value Per Share 2 | 2.600 | 2.850 | 3.120 | 3.350 | 3.350 | 3.720 | 4.070 |
| Cash Flow per Share 2 | 0.6100 | 0.6600 | 0.4700 | 0.5400 | 0.2300 | 0.7100 | - |
| Capex 1 | 744 | 693 | 1,325 | 941 | 1,143 | 903 | 500 |
| Capex / Sales | 12.34% | 10.13% | 18.87% | 13.46% | 12.86% | 9.82% | 4.64% |
| Announcement Date | 3/1/20 | 4/26/21 | 4/22/22 | 4/14/23 | 4/25/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
5.17
CNY
Average target price
7.567
CNY
Spread / Average Target
+46.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.72% | 1.75B | |
| +10.26% | 27.42B | |
| +11.16% | 12.11B | |
| +6.60% | 7.37B | |
| +0.83% | 4.31B | |
| -8.23% | 4.27B | |
| +20.00% | 4.01B | |
| -0.35% | 3.97B | |
| -17.27% | 3.81B | |
| -23.66% | 2.76B |
- Stock Market
- Equities
- 300088 Stock
- Financials Wuhu Token Sciences Co., Ltd.
